You are currently viewing AXXESS – The Self-Expanding Bifurcation DES– Device Overview and Clinical Data

AXXESS – The Self-Expanding Bifurcation DES– Device Overview and Clinical Data

EBC - ON DEMAND

AXXESS – The Self-Expanding Bifurcation DES– Device Overview and Clinical Data

European Bifurcation Club 2011 – EBC 2011 – Lisbon, Portugal

Biosensors sponsored symposium

AXXESS – The Self-Expanding Bifurcation DES– Device Overview and Clinical Data

Author: Ricardo A. Costa, Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil

 

DEVICE DESCRIPTION

  • Self-expanding nickel- titanium (Nitinol) alloy
  • Conical shape
  • Coated with Biolimus A9TM using a bioabsor-bable polymer matrix (PLA) in a dose of 22 μg/mm of stent length
  • Proximal and distal gold markers to facilitate implantation
  • First self-expanding coronary stent to incorporate a drug
  • First drug-eluting stent dedicated for the treatment of diseased coronary bifurcation lesions

CONCLUSION

  • The safety and efficacy of the Axxess Biolimus A9-eluting stent was confirmed up to 3 years
  • The use of Axxess stent for the treatment of complex bifurcation lesions resulted in low 3-year event rates:
    • Very low definite VLST not resulting in any death
    • Only one definite VLST attributed to the Axxess stent whereas all events were present in the Cypher stent

??

Download here

Leave a Reply